|
Most
people deny, ignore, or are oblivious to the
consequences of the synergistic effect of global
warming, population growth, global population aging,
obesity, substance abuse, sexually transmitted
diseases, hepatitis, tuberculosis, malaria,
antibiotic-resistant bacteria, and the impending
shortage of skilled caregivers. Therefore, they go
about their tasks and aspirations; unaware that we are
being permeated and overtaken by plagues whose outcome
is disaster.
Global warming will cause dramatic climate changes
that will cause droughts, floods and increase the spread of
disease. Population growth will compound this forthcoming
dilemma.
With global population aging alone, we will have
an imminent worldwide epidemic. Global population aging will
increase beyond the ability of medicine; it will bring about a
shortage of trained doctors, nurses and hospital facilities.
America’s older population will be about 70 million by 2030.
Obesity, heart disease, cancer, stroke, Alzheimer’s disease, and
diabetes are the big killers. By the year 2025, Alzheimer’s will
have crippled more than 22 million Americans and over 22 million
Americans will have developed diabetes. Diabetes is a leading
cause of blindness, kidney failure, amputations, and dramatically
raises the risk of heart attacks. The effect of global population
aging on the nation’s health care costs will be overwhelming.
Research shows that the number of overweight
people around the world has climbed to 1.1 billion. Obesity
contributes to many diseases including: heart disease, stroke,
diabetes, gallbladder disease, osteoarthritis, respiratory
problems, and certain cancers. It also raises the stress on
joints, often causing injury and pain. Obesity is no longer
simply a medical problem—but an epidemic that threatens global
well-being.
In the United States 61 percent of all adults are
overweight. It’s estimated that obesity-related diseases cost
Americans nearly 100 billion dollars annually (and climbing).
As of September 2000, nearly half of all Americans
suffer from at least one chronic disease. The nation is
unprepared to cope with the growing burden of chronic diseases,
infectious diseases, and sexually transmitted diseases.
The total economic cost of tobacco, alcohol and
other drug abuse on the U.S. economy exceeds $238 billion per
year. In addition, about $140 billion dollars is spent annually
treating conditions and complications related to tobacco, alcohol,
and other drug abuse. Substance abuse disorders severely affect
the non-abusing population as well.
The United States has one of the highest rates of
sexually transmitted diseases of all industrialized countries in
the world. STDs affect one in four U.S. citizens over a lifetime.
As of September 2000, more than 65 million Americans are infected
with one or more sexually transmitted diseases. There are an
estimated 15 million new infections annually, a quarter of them
among teenagers. The risks associated with STDs range from
sterility—to cancer—to death. It is just a matter of time before
major illnesses reach a critical level.
An effective way to reveal the future of HIV is to
parallel it with genital herpes—another virus with no incubation
period. Overall, genital herpes infections jumped 30% in the
United States from 1976 to 1994, with about one in five Americans
over 12 years of age having the sexually transmitted infection.
The data gathered suggest that over 45 million Americans are
infected with the genital herpes, high-risk behavior is prevalent,
and mother-child infection is widespread. It is estimated that
75% to 90% of all Americans have some form of herpes.
As of September 2000, AIDS has killed almost 20
million people worldwide and 2.6 million of those deaths were in
1999. Globally it is estimated that there are over 40 million
people infected with HIV. There were about 5.4 million newly
infected people in 1999.
The percentage of HIV-positive cases turning up at
anonymous testing centers in the United States has nearly tripled
between 1997 and 1999 to reach 3.7%—a level comparable to some
areas of sub-Saharan Africa.
As of September 2000, about 1 million Americans are infected with
HIV, and roughly, 40 percent are co-infected with hepatitis C;
there are over 44,000 new HIV infections every year, and it is
estimated that over half of the cases occur in teens and young
adults.
While the number of new AIDS diagnoses in the
United States declined in 1999 due to AIDS drug cocktails, the
incidence of HIV and HIV co-infected with hepatitis C continues to
increase.
There are three viruses A, B, and C that are
responsible for the vast majority of cases of acute and chronic
virus-associated hepatitis. There is another form identified as
autoimmune hepatitis, which is a chronic hepatitis that is caused
by a loss of tolerance against liver components in genetically
susceptible individuals. These major forms of hepatitis attack
the liver and can cause liver cell injury.
Hepatitis A is found in food and water. Annually
about 200,000 Americans and 10 million people worldwide contract
hepatitis A. What is increasing concern now is that people that
are already chronically infected with hepatitis B and C face a
high risk of dying if they contract hepatitis A. Different
viruses cause all three types of hepatitis. Infection with one
virus type offers no immunity from infection by another.
Hepatitis B is transmitted by human body fluids
such as blood, seminal fluid, vaginal secretions, breast milk,
tears, saliva, and open sores. Its methods of transmission
include mother to baby, during sexual contact, deep kissing, and
through the use of improper injection techniques. HBV is 100
times more infectious than HIV.
HBV is preventable with a vaccine. Nevertheless,
more than two billion individuals alive today have been infected
at some time in their lives with HBV, and approximately 350
million are chronically infected carriers of this virus. HBV is
one of the most common human pathogens, and it is the most
prevalent chronic virus infection worldwide. An estimated 140,000
Americans are infected each year with hepatitis B. Approximately
one to one and a quarter million Americans are chronically
infected and are considered to be carriers of the hepatitis B
virus.
Carriers of HBV are at high risk of serious
illness and death from cirrhosis of the liver and primary liver
cancer, diseases that kill more than one million carriers per
year. In addition, these carriers constitute a reservoir of
infected individuals who perpetuate the infection from generation
to generation. A carrier is infectious and can transmit hepatitis
B even though he/she has no signs or symptoms.
As of September 2000, it is estimated that 5
million Americans (some estimates go as high as 15 million) are
infected with hepatitis C; that there are up to 230,000 new
hepatitis C infections in the
U.S.
every year. About 8,000 to 10,000 Americans die of HCV annually,
and the toll is expected to triple in the next decade or two.
It is estimated that globally there are over 200
million people chronically infected with hepatitis C, and this
large reservoir of infected persons constitutes a daunting source
of potential new infections. HCV infection is the most common
type of chronic viral hepatitis in the developed world. People
who are already infected with HCV can get re-infected with
different sub-strains of HCV. Over the next 10-20 years, chronic
hepatitis B and C will become a major burden on the health care
system as patients who are currently asymptomatic with relatively
mild disease progress to end-stage liver disease.
If you have had a blood transfusion before 1992, a
tattoo or body piercing; if you have shared a straw used for
inhaling drugs, used IV drugs, been exposed to blood, had sex with
anyone at risk, or deeply kissed anyone who could be infected you
should be tested for hepatitis B and C. (Sharing personal care
items such as razors, toothbrushes, pierced earrings, fingernail
files, and clippers can put you a risk of contracting HBV and
HCV.)
After almost forty years of decline, tuberculosis
is again on the upswing. According to the World Health
Organization (WHO) nearly 2 billion people or one third of the
world’s population is currently infected with the TB bacillus.
Someone in the world is newly infected with TB every second.
Tuberculosis is an increasing and major worldwide
problem, especially now that many immune weakening diseases and
circumstances facilitate active TB. HIV/AIDS, hepatitis,
diabetes, old age, homelessness, malnutrition, heavy smoking, and
drug or alcohol abuse (to name but a few factors) weaken the
immune system, placing people at higher risk to get active TB.
Globally, there are an estimated 8 million cases and 2 million
deaths from tuberculosis every year. TB is the leading cause of
death from a single infectious agent in adults worldwide.
It is estimated that nearly 1 billion people will
become infected with tuberculosis, 200 million will become sick,
and 70 million will die worldwide between now and 2020. These
figures do not take into consideration that the drugs used to
fight TB are harmful to the liver, which affects millions of
people who are co-infected with chronic hepatitis. Furthermore,
these figures do not reflect the onset of MDR TB (multi-drug
resistant tuberculosis). MDR TB is a very dangerous form of
tuberculosis. Some TB germs become resistant to the effects of
the drugs used to fight TB.
The effects of TB and MDR TB will be increasingly
common and will intensify with the progression of the other
diseases.
Compounding this imminent medical disaster is that
people with HIV/AIDS or weak immune systems are more likely to
develop malaria. Annually over 500 million people (mostly
children) become ill with malaria and several million die. Every
30 seconds, a child somewhere dies of malaria.
In addition, antibiotic-resistant bacteria is
becoming increasingly common, and it will have a quite serious
effect on nearly every community.
Topping off this disaster is that fewer young
people are taking up the nursing profession in the United States.
This will result in an acute shortage of registered nurses in the
United States starting in 2010, when today’s nurses start to
retire.
These episodes illustrate the volatility of
infectious disease death rates and the unpredictability of disease
emergence.
There is compelling evidence that the
aforementioned scenarios will have a profound impact on future
rates of infant, child and maternal mortality, life expectancy,
and economic growth. These unprecedented impacts at the
macro-level are matched by the intense burden of suffering among
individuals and households. These factors are unique in their
devastating impact on the social, economic, and demographic
underpinnings of development.
The world’s population was about six billion in
2000. The way the population is growing; there could 8.9 billion
people by the year 2030. The way the these viruses and medical
problems are spreading, many experts agree that if left
unattended, the affect on the world’s health care costs will
procure a major disaster if the trends continue.
The full impact of the aforementioned scenarios in
terms of related illness, orphaned children, medical expenses
overriding their exchangeable value, unproductivity, and
mortality, is hard to perceive.
|